Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection

Journal of Clinical Investigation

Volumn 117, Issue 10, 2007, Pages 3067-3074

  Leligdowicz, Aleksandra ^a,b   Yindom, Louis Marie ^a   Onyango, Clayton ^a   Sarge Njie, Ramu ^a   Alabi, Abraham ^a   Cotten, Matthew ^a   Vincent, Tim ^a,c   Da Costa, Carlos ^c   Aaby, Peter ^c   Jaye, Assan ^a   Dong, Tao ^b   McMichael, Andrew ^b   Whittle, Hilton ^a   Rowland Jones, Sarah ^a,b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c Projecto Saude Bandim ^*  (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; NEF PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

AMINO ACID SEQUENCE; FEMALE; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-2; HUMANS; INTERFERON TYPE II; MALE; MOLECULAR SEQUENCE DATA; PROTEOME; T-LYMPHOCYTES; VIREMIA;

EID: 34948834270     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32380     Document Type: Article

References (48)

1. Marlink, R., et al. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 265:1587-1590.
2. Berry, N., et al. 2002. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res. Hum. Retroviruses. 18:1167-1173.
3. Andersson, S., et al. 2000. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch. Intern. Med. 160:3286-3293.
4. Popper, S.J., et al. 2000. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J. Virol. 74:1554-1557.
5. Guyader, M., et al. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 326:662-669.
6. Whittle, H., et al. 1992. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS. 6:685-689.
7. Ariyoshi, K., et al. 2000. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS. 14:339-344.
8. Bertoletti, A., et al. 1998. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J. Virol. 72:2439-2448.
9. Gotch, F., et al. 1993. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 151:3361-3369.
10. Sarr, A.D., et al. 2001. Robust HIV type 2 cellular immune response measured by a modified anthrax toxin-based enzyme-linked immunospot assay. AIDS Res. Hum. Retroviruses. 17:1257-1264.
11. Duvall, M.G., et al. 2006. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 176:6973-6981.
12. Lopes, A.R., et al. 2003. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J. Immunol. 171:307-316.
13. Rowland-Jones, S., et al. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
14. Ogg, G.S., et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 279:2103-2106.
15. Walker, B.D., et al. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 328:345-348.
16. Borrow, P., Lewicki, H., Hahn, B.H., Shaw, G.M., and Oldstone, M.B. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
17. Addo, M.M., et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77:2081-2092.
18. Masemola, A., et al. 2004. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J. Virol. 78:3233-3243.
19. Betts, M.R., et al. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
20. Novitsky, V., et al. 2002. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J. Virol. 76:10155-10168.
21. Kaufmann, D.E., et al. 2004. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78:4463-4477.
22. Cao, J., et al. 2003. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J. Virol. 77:6867-6878.
23. Yu, X.G., et al. 2002. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J. Virol. 76:8690-8701.
24. Edwards, B.H., et al. 2002. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76:2298-2305.
25. Kalams, S.A., et al. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J. Virol. 73:6715-6720.
26. Rinaldo, C., et al. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
27. Gillespie, G.M., et al. 2005. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur. J. Immunol. 35:1445-1453.
28. Ariyoshi, K., et al. 1995. HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load. AIDS. 9:555-559.
29. Zheng, N.N., et al. 2004. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J. Virol. 78:13934-13942.
30. Jaye, A., et al. 2004. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. J. Infect. Dis. 189:498-505.
31. Poulsen, A.G., et al. 1993. HIV-2 infection in Bissau, West Africa, 1987-1989: incidence, prevalences, and routes of transmission. J. Acquir. Immune Defic. Syndr. 6:941-948.
32. Wilkins, A., et al. 1993. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS. 7:1119-1122.
33. Ramduth, D., et al. 2005. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses. J. Infect. Dis. 192:1588-1596.
34. Kiepiela, P., et al. 2007. CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13:46-53.
35. Currier, J.R., et al. 2006. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response. BMC Immunol. 7:8.
36. Goulder, P.J., et al. 2000. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J. Virol. 74:5679-5690.
37. Malhotra, U., et al. 2001. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J. Clin. Invest. 107:505-517.
38. Ogg, G.S., et al. 1998. Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509). AIDS. 12:1561-1563.
39. Gamble, T.R., et al. 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 278:849-853.
40. Provitera, P., et al. 2001. Role of the major homology region in assembly of HIV-1 Gag. Biochemistry. 40:5565-5572.
41. Mammano, F., Ohagen, A., Hoglund, S., and Gottlinger, H.G. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:4927-4936.
42. Martinez-Picado, J., et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
43. Melamed, D., et al. 2004. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release. J. Virol. 78:9675-9688.
44. Tsomides, T.J., et al. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
45. Chertova, E., et al. 2006. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80:9039-9052.
46. Sacha, J.B., et al. 2007. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178:2746-2754.
47. Berry, N., et al. 1998. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1:457-468.
48. Roederer, M., and Koup, R.A. 2003. Optimized determination of T cell epitope responses. J. Immunol. Methods. 274:221-228.